Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-03

Clinical Trial Update: Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

View source ↗

Summary

A clinical trial comparing the incidence of dyskinesia in Parkinson's disease patients treated with amantadine versus a dopamine agonist; the current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dopamine agonist
  • amantadine (amantadine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson's Disease | Status: UNKNOWN